Nintendo (NTDOY) vs. Its Competitors Critical Comparison

Nintendo (OTCMKTS: NTDOY) is one of 323 public companies in the “Private households” industry, but how does it weigh in compared to its competitors? We will compare Nintendo to related companies based on the strength of its earnings, valuation, analyst recommendations, institutional ownership, profitability, risk and dividends.

Profitability

How to Become a New Pot Stock Millionaire

This table compares Nintendo and its competitors’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Nintendo 16.12% 9.07% 7.56%
Nintendo Competitors 9.97% 11.27% 4.90%

Dividends

Nintendo pays an annual dividend of $0.09 per share and has a dividend yield of 0.2%. Nintendo pays out 24.3% of its earnings in the form of a dividend. As a group, “Private households” companies pay a dividend yield of 1.7% and pay out 34.4% of their earnings in the form of a dividend.

Analyst Recommendations

This is a summary of current ratings and price targets for Nintendo and its competitors, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nintendo 1 1 2 0 2.25
Nintendo Competitors 714 2161 1807 78 2.26

Nintendo currently has a consensus target price of $66.00, indicating a potential upside of 27.46%. As a group, “Private households” companies have a potential downside of 3.64%. Given Nintendo’s higher probable upside, equities research analysts clearly believe Nintendo is more favorable than its competitors.

Institutional and Insider Ownership

0.1% of Nintendo shares are owned by institutional investors. Comparatively, 46.1% of shares of all “Private households” companies are owned by institutional investors. 0.9% of shares of all “Private households” companies are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Valuation and Earnings

This table compares Nintendo and its competitors gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Nintendo $4.52 billion $902.65 million 139.95
Nintendo Competitors $13.04 billion $1.05 billion 18.68

Nintendo’s competitors have higher revenue and earnings than Nintendo. Nintendo is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.

Risk and Volatility

Nintendo has a beta of 0.88, meaning that its share price is 12% less volatile than the S&P 500. Comparatively, Nintendo’s competitors have a beta of 0.92, meaning that their average share price is 8% less volatile than the S&P 500.

Summary

Nintendo competitors beat Nintendo on 9 of the 15 factors compared.

Nintendo Company Profile

Nintendo Co., Ltd. is mainly engaged in the development, manufacture and sale of entertainment products in home entertainment field. The Company’s main products include leisure machines such as portable and console game machines and software, as well as trump and Carta (Japanese-style playing cards). As of March 31, 2014, the Company had 29 subsidiaries and six associated companies.

Receive News & Ratings for Nintendo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nintendo and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Cantor Fitzgerald Raises Intuitive Surgical  Price Target to $510.00
Cantor Fitzgerald Raises Intuitive Surgical Price Target to $510.00
JPMorgan Chase Boosts UnitedHealth Group  Price Target to $266.00
JPMorgan Chase Boosts UnitedHealth Group Price Target to $266.00
Mizuho Reaffirms “Buy” Rating for QUALCOMM
Mizuho Reaffirms “Buy” Rating for QUALCOMM
Noah  and PJT Partners  Critical Review
Noah and PJT Partners Critical Review
Head-To-Head Analysis: The Meet Group  & Quotient Technology
Head-To-Head Analysis: The Meet Group & Quotient Technology
Mersana Therapeutics  Stock Rating Upgraded by Zacks Investment Research
Mersana Therapeutics Stock Rating Upgraded by Zacks Investment Research


© 2006-2018 Ticker Report. Google+.